Presentations about advertising therapeutic goods in Australia
**These presentation papers are provided on the TGA's website solely for the purpose of indicating or suggesting what TGA representatives spoke about to the various conferences and seminars to which they relate. The papers are not legislative in nature and should not be taken to be statements of any law or policy in any way.
The Australian Government Department of Health and Ageing (of which the TGA is a division) advises that (a) the presentation papers should not be relied upon in any way as representing a comprehensive description of regulatory requirements, and (b) cannot guarantee, and assumes no legal liability or responsibility for, the accuracy, currency or completeness of the information contained in the presentation papers.**
Regulating the advertising of therapeutic goods in Australia
21-24 April 2010
Presentation: Regulating the advertising of therapeutic goods in Australia (pdf,198kb)
Presented by: Craig Davies, Director: Advertising and Export Section, Office of Non Prescription Medicines, TGA
Presented at: Cosmetex 2010: Annual Joint Conference of the Australasian College of Cosmetic Surgery and the Cosmetic Physicians Society of Australasia, Adelaide Convention Centre, Adelaide, 21-24 April 2010
Summary of presentation: This presentation provides information about one of the specific advertising requirements of the Therapeutic Goods Act 1989 (The Act) and the concern the TGA has with certain promotional activities which are occurring in the marketplace. The Act includes offences relating to advertisements for therapeutic goods to consumers including one such offence that prohibits the advertising of Schedule 4 ('prescription-only') products. Injectable and implantable preparations for cosmetic use and/or tissue augmentation such as botulinum toxin, hyaluronic acid, polyacrylamide and polylactic acid are regulated as 'prescription-only' therapeutic goods and therefore may not lawfully be advertised to consumers.
The majority of conference delegates included cosmetic surgeons, cosmetic physicians and the owners/managers of beauty salons/clinics.
The Therapeutic Good Advertising Code explained
23-24 September 2009
Presentation: The Therapeutic Good Advertising Code explained (pdf,233kb)
Presented by: Susan Anido, Head - Advertising Unit, Office of Non Prescription Medicines, TGA
Presented at: Medical Technology Association of Australia (MTAA) Annual Conference, Star City, Sydney, 23-24 September 2009
Advertising medical devices to consumers: The MTAA Code of Practice applies to the medical technology industry. In addition to the Code, the Therapeutic Goods Advertising Code (TGAC) administered by the Therapeutic Goods Administration (TGA), regulates direct to consumer advertising of medical products. This presentation provides information about what is regulated under the TGAC and what are some of the implications of direct to consumer advertising. It also provides some education and inside knowledge about the procedures applying to the TGAC.